JACC: Case Reports (Mar 2024)
Dobutamine-Induced Myoclonus in a Patient With Advanced Heart Failure and Chronic Kidney Disease
Abstract
Dobutamine is a positive inotropic agent often used in treatment of cardiogenic shock. Although there are well-documented adverse effects, dobutamine-induced myoclonus is a rarely reported phenomenon. Our case offers a direct and temporally related description of myoclonus, with onset observed within hours of dobutamine initiation and complete resolution within minutes of discontinuation.